Ventas, Inc. (VTR)
NYSE: VTR · Real-Time Price · USD
89.05
+1.62 (1.85%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Ventas Employees
Ventas had 542 employees as of December 31, 2025. The number of employees increased by 44 or 8.84% compared to the previous year.
Employees
542
Change (1Y)
44
Growth (1Y)
8.84%
Revenue / Employee
$11,278,317
Profits / Employee
$480,489
Market Cap
43.60B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 542 | 44 | 8.84% |
| Dec 31, 2024 | 498 | 12 | 2.47% |
| Dec 31, 2023 | 486 | 35 | 7.76% |
| Dec 31, 2022 | 451 | 17 | 3.92% |
| Dec 31, 2021 | 434 | -14 | -3.13% |
| Dec 31, 2020 | 448 | -68 | -13.18% |
| Dec 31, 2019 | 516 | 16 | 3.20% |
| Dec 31, 2018 | 500 | 7 | 1.42% |
| Dec 31, 2017 | 493 | 0 | - |
| Dec 31, 2016 | 493 | 27 | 5.79% |
| Dec 31, 2015 | 466 | -13 | -2.71% |
| Dec 31, 2014 | 479 | 14 | 3.01% |
| Dec 31, 2013 | 465 | 26 | 5.92% |
| Dec 31, 2012 | 439 | 111 | 33.84% |
| Dec 31, 2011 | 328 | 65 | 24.71% |
| Dec 31, 2010 | 263 | 202 | 331.15% |
| Dec 31, 2009 | 61 | -2 | -3.17% |
| Dec 31, 2008 | 63 | 10 | 18.87% |
| Dec 31, 2007 | 53 | 16 | 43.24% |
| Dec 31, 2006 | 37 | 5 | 15.63% |
| Dec 31, 2005 | 32 | 7 | 28.00% |
| Dec 31, 2004 | 25 | 2 | 8.70% |
| Dec 31, 2003 | 23 | 0 | - |
| Dec 31, 2002 | 23 | 9 | 64.29% |
| Dec 31, 2001 | 14 | 3 | 27.27% |
| Dec 31, 2000 | 11 | 1 | 10.00% |
| Dec 31, 1999 | 10 | 3 | 42.86% |
| Dec 31, 1998 | 7 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Welltower | 712 |
| Healthcare Realty Trust | 539 |
| Healthpeak Properties | 411 |
| American Healthcare REIT | 121 |
| Medical Properties Trust | 121 |
| Omega Healthcare Investors | 69 |
| Sabra Health Care REIT | 58 |
| CareTrust REIT | 43 |
VTR News
- 5 days ago - Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research - Business Wire
- 9 days ago - Ventas price target lowered to $88 from $95 at Scotiabank - TheFly
- 11 days ago - Ventas resumed with an Outperform at Raymond James - TheFly
- 11 days ago - Ventas price target raised to $100 from $95 at Deutsche Bank - TheFly
- 24 days ago - Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement - Business Wire
- 26 days ago - Ventas affirms FY26 FFO view of $3.82-$3.89, consensus $3.87 - TheFly
- 26 days ago - Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference - Business Wire
- 26 days ago - Ventas Slides: Investor presentation - Filings